Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

Technology Scientific & Technical Instruments
RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair... see more

Recent & Breaking News (TSXV:RP)

RepliCel Life Sciences Announces Leadership Transition

Marketwired December 16, 2015

RepliCel Life Sciences Inc. Announces Closing of First Tranche of Private Placement

Canada NewsWire November 23, 2015

CIX Public Top 20 Spotlight Podcast: RepliCel Life Sciences (V.RP)

Gaalen Engen November 13, 2015

RepliCel Executives to Present at 9th World Congress for Hair Research in Miami

Canada NewsWire November 12, 2015

RepliCel Selected as One of This Year's Top 20 Public Canadian Technology Companies

Canada NewsWire November 4, 2015

CIX Public Top 20 Update: RepliCel Life Sciences (V.RP)

Gaalen Engen October 30, 2015

RepliCel Life Sciences Inc. Announces Brokered Private Placement

Canada NewsWire October 20, 2015

First Participants Enrolled in RepliCel's Phase 1 Clinical Trial of its RCS-01 Dermatology Injectable

Canada NewsWire October 20, 2015

Industry Leader Geoff MacKay Joins RepliCel Life Sciences' Board of Directors

Canada NewsWire October 15, 2015

RepliCel Announces October Presentation and Partnering Meeting Schedule

Canada NewsWire October 8, 2015

RepliCel Presenting at Two Upcoming Investment and Partnering Forums

PR Newswire September 23, 2015

CIX snapshot: Public Top 20 contenders you should know about

Gaalen Engen September 18, 2015

RepliCel Life Sciences Announces Initiation of Clinical Site and Participant Recruitment for European Skin Aging Study

PR Newswire September 15, 2015

BioWatch's Alan Leong Interviewed by The Life Sciences Report

Marketwired September 10, 2015

RepliCel Life Sciences Cleared to Initiate Clinical Trial of RCS-01 for Dermal Rejuvenation

Canada NewsWire September 1, 2015

RepliCel Reports Second Quarter 2015 Financial Results

Canada NewsWire August 28, 2015

RepliCel Presenting at InvestMNT Investor Conference in Minneapolis

Canada NewsWire August 3, 2015

RepliCel Presenting at InvestMNT Investor Conference in Minneapolis

Canada NewsWire August 3, 2015

RepliCel Presenting at InvestMNT Investor Conference in Minneapolis

Canada NewsWire August 3, 2015

RepliCel Presenting at InvestMNT Investor Conference in Minneapolis

Canada NewsWire August 3, 2015